HECHT BETH (See Remarks) sold 1.3% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $124.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/2/2026ACC: 0001652410-26-000004
Officer· See Remarks
Since Oct 2021
+97.23K
Net shares
Net buyer
$1.37M
Total sold
1
Open market trades
0B · 1S
6
Total transactions
283.45K acquired · 186.22K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
+121.29K
Price / share
—
Trade value
—
% of position
9.3%
1/30/2026
1.31M→1.43M
Common Stock
Direct
Shares
−98.38K
Price / share
$7.36
Trade value
$724.04K
% of position
6.9%
1/31/2026
1.43M→1.33M
Common Stock
Direct
Shares
−46.91K
Price / share
$7.36
Trade value
$345.29K
% of position
3.5%
1/31/2026
1.33M→1.28M
Common Stock
Direct
Shares
−24.27K
Price / share
$7.36
Trade value
$178.60K
% of position
1.9%
1/31/2026
1.28M→1.26M
Common Stock
Direct
Shares
−16.67K
Price / share
$7.45
Trade value
$124.15K
% of position
1.3%
2/2/2026
1.26M→1.24M
Total
Net shares
−64.93K
Net value
-$1.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2026 | A · Award | +121.29K | — | — | 9.3% | 1.31M | 1.43M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −98.38K | $7.36 | $724.04K | 6.9% | 1.43M | 1.33M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −46.91K | $7.36 | $345.29K | 3.5% | 1.33M | 1.28M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −24.27K | $7.36 | $178.60K | 1.9% | 1.28M | 1.26M |
| Common Stock Direct | 2/2/2026 | S · Sale | −16.67K | $7.45 | $124.15K | 1.3% | 1.26M | 1.24M |
| Total | −64.93K | -$1.37M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
162.16K shares
Shares
+162.16K
Strike price
7.36
Held after
162.16K
Exercisable
—
1/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock162.16K shares | 1/30/2026 | A · Award | +162.16K | 7.36 | — | 162.16K |